Clinical Research Services Contract
To provide services in respect of conducting a multinational Phase II study in non-cystic fibrosis BE patients, sponsored by Novartis, across Europe.
United Kingdom-Belfast: Research services
2020/S 017-036971
Contract notice
Services
Directive 2014/24/EU
Section I: Contracting authority
I.1)Name and addresses
Postal address: University Road
Town: Belfast
NUTS code: UKN06
Postal code: BT7 1NN
Country: United Kingdom
Contact person: Pamela Rodgers
E-mail: pamela.rodgers@qub.ac.uk
Telephone: +44 2890973026
Address of the buyer profile: https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
I.3)Communication
I.4)Type of the contracting authority
I.5)Main activity
Section II: Object
II.1.1)Title:
QUB/1850/20 Contract for Clinical Research Services (Clinical Research Organisation)
II.1.2)Main CPV code
II.1.3)Type of contract
II.1.4)Short description:
Queen’s University Belfast seeks to appoint a clinical research organisation (CRO) to provide services in respect of conducting a multinational Phase II study in non-cystic fibrosis BE patients, sponsored by Novartis, across Europe. The trial will be jointly funded by Novartis and the EU Innovative Medicines Initiative (IMI) through the iABC consortium. IMI is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients (http://www.imi.europa.eu/). Access to tender documentation is restricted to those companies who download, complete and submit a CDA to Queen’s.
II.1.6)Information about lots
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
The CRO must have the capability to manage a study across multiple EU countries.
II.2.4)Description of the procurement:
Queen’s University Belfast seeks to appoint a clinical research organisation (CRO) to provide services in respect of conducting a multinational Phase II study, sponsored by Novartis, across Europe.
II.2.5)Award criteria
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Option to extend by up 2 years.
II.2.10)Information about variants
II.2.11)Information about options
Two years with the option to extend by up 2 years.
II.2.13)Information about European Union funds
II.2.14)Additional information
Section III: Legal, economic, financial and technical information
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
III.2.2)Contract performance conditions:
The CRO must be capable of conducting a randomised phase II clinical study across Europe.
Section IV: Procedure
IV.1.1)Type of procedure
Queen’s will be availing of Article 27 (3), Public Contracts Regulations 2015; where a state of urgency duly substantiated by the contracting authority renders impracticable the time limit laid down in the second subparagraph of paragraph 1, it may fix a time limit which shall be not less than 15 days from the date on which the contract notice was sent. Requirement was previously tendered under QUB/1850/19, OJEU Reference 2019/S 221-542205.
IV.1.8)Information about the Government Procurement Agreement (GPA)
IV.2.2)Time limit for receipt of tenders or requests to participate
IV.2.4)Languages in which tenders or requests to participate may be submitted:
IV.2.7)Conditions for opening of tenders
Section VI: Complementary information
VI.1)Information about recurrence
VI.3)Additional information:
Economic operators seeking to obtain tender documentation, must first download, complete and submit a confidential disclosure agreement (CDA). Tender documents will not be issued until a completed CDA has been received via correspondence on Intend.
VI.4.1)Review body
Postal address: University Road
Town: Belfast
Postal code: BT7 1NN
Country: United Kingdom
E-mail: procurement@qub.ac.uk
VI.4.3)Review procedure
VI.5)Date of dispatch of this notice: